Date closed: 2/23/16
Value : C$12.075 million
On February 23, 2016, Titan Medical Inc. (Titan) completed an overnight marketed offering of units consisting of one common share and one common share purchase warrant for aggregate gross proceeds of $12,075,000 (the Offering). Bloom Burton & Co. Limited acted as agent and Roth Capital Partners acted as special selling group member on the Offering.
Titan, headquartered in Toronto, Ontario, is focused on the design and development of a robotic surgical system for application in minimally invasive surgery.